UPDATE: Stifel Reiterates Buy Rating, Raises PT on Medidata Solutions, Inc. on Management Meeting Recap

In a report published Tuesday, Stifel analyst Steven Rubis reiterated a Buy rating on

, and raised the price target from $55.00 to $60.00. In the report, Stifel noted, "On Tuesday, March 17, Medidata Solutions met with several institutional investors. We were able to meet with Medidata's CEO Tarek Sherif, and President Glen de Vries to discuss key topics facing Medidata Solutions. The key topics of discussion revolved around: Medidata Solutions place in the mHealth eco-system, Apple's ResearchKit, the GlaxoSmithKline and Veeva Systems news, Alan Mateo's hiring by Veeva Systems, and Medidata's strategic consulting services, as well as risk-based monitoring. We provide our thoughts stemming from our discussion with management." Medidata Solutions, Inc. closed on Monday at $50.08.